T1	Intervention 507 816	Monthly pre-enalapril and post-enalapril neurohormone levels (serum ACE activity (sACE), plasma angiotensin II (A-II), plasma renin activity (PRA), and serum aldosterone (ALDO) were compared between genotype subgroups and between patients who received high- or low-dose enalapril within each genotype subgroup
T2	Intervention 412 505	randomly assigned to receive either high-dose or low-dose enalapril over a period of 6 months
